drugset / Trial / NCT02776540

Clopidogrel for Acute Ischaemia of Recent Onset

NCT02776540 ↗

Phase 4 Completed 188 enrolled Ain Shams University
RandomizedParallel-groupTriple-blindTreatment

Summary

Evaluate the role of loading Clopidogrel in acute ischemic stroke in improving neurological outcome of stroke in cases patients will be non-eligible for, or declined, treatment with or intravenous thrombolysis with rTPA, rTPA is not available or thrombectomy.

Timeline

Start
2016-06-01
Primary completion
2019-02-01
Completion
2019-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 300 mg —
Comparator Aspirin Small molecule 400 mg —
Comparator Clopidogrel Small molecule 600 mg —
Comparator Clopidogrel Small molecule 900 mg —

Indications